Skip to main content

Table 1 Characteristic of patients cohort

From: The value of shock index in prediction of cardiogenic shock developed during primary percutaneous coronary intervention

 

Non-Shock (n = 769)

Developed Shock (n = 101)

P value

Age,year[M(IQR)]

64(55–74)

63(55–73)

0.52

Male sex,n(%)

610(79.3)

76(75.6)

0.35

Anterior myocardial infarction,n(%)

389(50.6)

58(57.6)

0.2

Hypertension,n(%)

505(65.7)

69(68.8)

0.60

Diabetes,n(%)

215(28.0)

34(33.3)

0.23

Prior Stroke,n(%)

101(13.1)

30(30.3)

< 0.001

Hyperlipidemia,n(%)

64(9.7)

9(9.1)

0.84

Smoke,n(%)

450(58.5)

53(52.1)

0.25

Prior myocardial infarction, n(%)

73(9.53)

8(7.98)

0.61

Creatinine,μmol/L[M(IQR)]

72(62–87)

69(60–81)

0.22

EF,%[M(IQR)]

47(41–50)

44(40–48)

0.03

Triglyceride, mmol/L[M(IQR)]

1.38(1.00–2.05)

1.39(0.90–2.10)

0.72

Cholesterol, mmol/L[M(IQR)]

4.28(3.63–4.98)

4.49(3.83–4.88)

0.46

LDL-C, mmol/L[M(IQR)]

2.31(1.84–2.80)

2.29(1.91–2.79)

0.93

HDL-C, mmol/L[M(IQR)]

0.93(0.76–1.14)

0.91(0.77–1.11)

0.79

Pre-procedure SBP, mmHg[M(IQR)]

123(112–138)

104(96–108)

< 0.001

Pre-procedure HR, bpm[M(IQR)]

79(69–89)

91(82–100)

0.008

Total ischemic time,min[M(IQR)]

342(234–610)

360(267–713)

0.26

Killips class II/III, n(%)

185(24.0)

30(28.7)

0.50

Double vessel disease, n(%)

310(40.3)

34(33.3)

0.20

Triple vessel disease, n(%)

235(30.6)

40(39.4)

0.07

IRA

 LAD, n(%)

389(50.6)

58(57.6)

0.20

 LCX/OM, n(%)

123(16)

1(0.99)

< 0.001

 RCA, n(%)

195(25.4)

43(42.4)

< 0.001

 PDA/PL, n(%)

65(8.5)

0

–

 PTCA, n(%)

12(1.51)

0

–

Stents

 Sirolimus, n(%)

481(62.6)

58(57.6)

0.32

 Everolimus, n(%)

231(30.1)

30(30.3)

0.95

 Zotarolimus, n(%)

155(20.1)

24(24.2)

0.40

 Paclitaxel, n(%)

6(0.76)

0

–

Mediction

 Aspirin, n(%)

769(100)

101(100%)

1.00

 Clopidogrel, n(%)

516(67.1)

64(63.4)

0.45

 Ticagrelor, n(%)

253(32.9)

37(36.6)

0.45

 ACEI/ARB, n(%)

511(66.5)

64(63.6)

0.54

 β-blocker, n(%)

606(78.8)

70(69.4)

< 0.001

 Spironolactone, n(%)

442(57.5)

63(62.7)

0.35

 Diuretics, n(%)

359(46.7)

55(54.5)

0.14

 Statin, n(%)

767(99.8)

100(99.6)

0.31

  1. EF ejection fraction, LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol, SBP systolic blood pressure, HR heart rate, IRA infarct related artery, LAD left anterior descending branch, LCX left circumflex branch, OM obtuse marginal branch, RCA right coronary artery, PDA posterior descending artery, PL posterior branch of left venticule, ACEI angiotensin converting enzyme inhibitor, ARB angiotensin receptor blocker